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ﬁelds of view showing an intermediate to high amount of extracel-
lular iron aggregates compared to ferucarbotran in both cell-types
(11.1 - 19.3% vs 47.6 - 57.2%) (Figure 1C, D).
Conclusions:We have shown that ferumoxides-protamine is more
effective and speciﬁc compared to ferucarbotran for labelling of
hBMSCs and chondrocytes using SPIO. In order to verify the
effectiveness and safety of cell therapies for cartilage repair, this
provides major opportunities for clinically applicable cell tracking
in an intra-articular environment.
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Purpose: The efﬁciency of cartilage regeneration is thought to
be highly affected by the chemical and mechanical properties
of engineered cartilage before implantation. The physicochemical
properties of cartilage implants go through the biological matura-
tion and structural remodeling after implantation as well as during
the engineering process.
The purpose of present study was to evaluate the maturity and
remodeling of a scaffold-free chondrocytes aggregates from young
human sources in vitro and ex vivo using explants of human
femoral condyle.
Methods: 1. Cell source and the scaffold-free system: Human
chondrocytes were isolated from the polydactyly tissues from 3
patients (1or 2 years old) and cultured in our scaffold-free cartilage
fabrication system, previously described. The fabricated scaffold-
free chondrocytes aggregate was cultivated in vitro for 1, 7, 21,
and 35 days before various assays. 2. Ex vivo cartilage tissue
regeneration system: Full thickness osteochondral defect (d = 5
mm) was created in the explant of human lateral femoral condyle
from 5 patients undertaken joint replacement surgery (age range
of 64-74 years). The defects of explants were left empty as a
negative control (group 1) or ﬁlled with the scaffold-free chondro-
cytes aggregate cultured for 7 days in vitro by press-ﬁtting method
(group 2). The autologous osteochondral tissue (AOTS) was used
as a positive control group (group 3). The explants with each
construct were implanted subcutaneously into the back of nude
mice and incubated for 4 weeks. 3. Evaluation of the fabricated
constructs in vitro and ex vivo: The scaffold-free chondrocytes
aggregate fabricated in vitro and ex vivo were evaluated by macro-
scopic observation, quantitative biochemical analysis, histological
assays and mechanical test. The ratio between the contents of
chondroitin sulfate-4 and -6 were also evaluated.
Results: In the static culture system in vitro, the scaffold-free
chondrocyte aggregate formed a white disk-shape construct with
rather irregular surface at all time points until 35 days. However, the
amount of GAG and collagen increased until 21 days and reached
plateau afterward. When the scaffold-free chondrocyte aggregate
cultured for 7 days in vitro was implanted into the ex vivo model,
both of the contents of biochemical components (DNA, GAG and
collagen) and mechanical strength were signiﬁcantly higher than
those cultured in vitro for 35 days and were more than 50% of
those of native cartilage tissues. The histochemical observations
showed positive staining of sulfated proteoglycans and type II
collagen although they were not as strong as those of native
tissues. In the Safranin-O staining, it appeared integrated with
host tissues better than AOTS group did. Furthermore a little bit
of collagen ﬁber formation was also observed in the Sirius red
staining.
Conclusions: In the present study, we showed that the scaffold-
free aggregates of human polydyctyly chondrocytes were fabri-
cated well into the cartilage-like structure in vitro and ex vivo in the
histochemcial, biochemical and mechanical analyses. This result
suggests that our scaffold-free fabrication system using young
human chondrocytes could be a potential treatment to regener-
ate the cartilage defect in human. To our knowledge, this is the
ﬁrst report to apply chondrocytes from polydactyly patients to the
scaffold-free system for cartilage regeneration.
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Purpose: In the past years attention has been focused on the
promising technology of cell-assisted repair that propose the use
of autologous chondrocytes for the treatment of cartilage lesions
due to traumatic events. The opportunity to enlarge the indications
to the treatment of early degenerative changes in OA patients is
very intriguing. Even if the use of MSCs as a pure cell lineage
has been advocated for cartilage repair to overcome problems
associated with donor-site morbidity, cell de-differentiation and
the limited lifespan of chondrocytes, the opportunity to implant
concentrated bone marrow in a single operative procedure is of
great importance. The rationale lies in the key role of bone marrow
microenvironment (or“niche”) which contains not only stem cells
and precursors cells as a source of regeneration tissue, but also
accessory cells that support angiogenesis and vasculogenesis by
producting several growth factors and cytokines.
Aim of the research was directed toward the conduction of an
in vitro study to characterize human concentrated bone marrow-
derived cells (BMDc) and their ability to differentiate into cartilage
and bone.
Methods: Human bone marrow was obtained from the posterior
iliac crest of patients underwent autologous cell transplantation
for osteochondral defects and directly concentrated in operative
room by a cell separator. To characterize BMDc a series of
cellular markers has been evaluated using monoclonal antibodies
anti- CD45, CD34, CD54, CD63, CD90, CD105, CD106, CD146,
CD271 by ﬂow cytometric analysis. The ability of the cells to
form colonies was analized by CFU-F test. The potentiality of
concentrate cells to differentiate into chondrogenic and osteogenic
lineages was analyzed after culturing the cells up to 28 days in
differentiating media and evaluated by Alcian Blue and Alizarin red
S staining.
Results: BMDc expressed CD34, CD45, CD54 and CD63 at
the same levels as isolated MSCs, while CD90, CD105, CD106,
CD146 and CD271 were highly expressed in BMDc compared
to MSCs. BMDc were able to form colonies and once they are
cultured in chondrogenic medium added with TGFβ were positive
for Alcian Blue staining on day 28 showing the presence of
extracellular matrix speciﬁc molecules. At the same experimental
time, a lot of colonies positive to Alizarin red S in BMDc cultured in
osteogenic medium were found. Calcium precipitates were evident
inside the colonies.
Conclusions: Bone and cartilage defects are common features of
joint diseases in OA. Despite progress in orthopaedic surgery, the
repair of these tissues is a major challenge as they do not sponta-
neously heal. The chance to use autologous cell transplantation in
degenerative lesions in OA patients represents an important ther-
apeutical strategy for the disease. Patients could beneﬁt of such
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"biological" approach which is less invasive, simpler and cheaper
compared to prosthesis implants. In recent years a great deal has
been learnt about the isolation, cultivation and characterization
of MSCs due to their potential use in regenerative medicine and
tissue engineering. We demonstrated that BMDc have the same
phenotypical and functional characteristics of MSCs but easily
obtainable and usable in a “one step” procedure avoiding cell
isolation and expansion.
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Purpose: Previous studies have pointed to the importance of
subchondral bone restoration in the repair of cartilage defects.
In osteochondral defects, it may be necessary to restore the
underlying bone to facilitate the successful repair of cartilage.
Biodegradable scaffolds and demineralized cortical bone have
been investigated for the repair of focal defects. However, those
materials have had varying levels of success.
This study investigates the use of a novel allograft sponge of dem-
ineralized cancellous bone to ﬁll and repair osteochondral defects
in a goat model. It was hypothesized that the unique properties
of this sponge would facilitate restoration of the subchondral bone
with subsequent ﬁll of the cartilage defect, and support integration
with the surrounding tissues.
Methods: Osteochondral defects (4.5mm Ø, 8mm depth) were
created in the trochlear groove of goats. Two defects were cre-
ated; one defect ﬁlled with acellular allograft sponge (Bacterin) and
the other ﬁlled with an autograft core. The sponge is a demineral-
ized goat cancellous bone plug created similarly to commercially-
available human allograft products (OsteoSponge™. The knee was
splinted for 2 weeks. After 12 months, the animals were sacriﬁced
and the defects underwent macroscopic scoring, MRI morpho-
logical analysis, microCT scanning, and histological scoring. Data
were analyzed using one-way ANOVA with data shown as average
± SD with 4 replicates.
Results: All defects were ﬁlled with white and glistening repair
tissue at 12 months and the defects scored similarly in gross
appearance. Defects were generally ﬁlled with tissue that was
ﬂush to the native cartilage based on histological and MRI analy-
sis. Restoration of bone was similar for the sponge and autograft
groups and all samples demonstrated complete osseous incor-
poration on MRI. Tidemark restoration was partial or complete
for most of the sponge samples. Histological and MRI analysis
demonstrated cartilage repair tissue that resembled hyaline carti-
lage, with histological scores being similar between the groups for
matrix staining, cell morphology, defect architecture, and surface
architecture. Histological scores for integration were signiﬁcantly
higher for the sponge-treated defects when compared to the con-
trols (p<0.001, Fig. 1).
Conclusions: The novel DBM sponge used in this study was
shown to support subchondral bone restoration in focal osteo-
chondral defects and resulted in defect ﬁll similar to that observed
for the autograft controls. The sponge’s unique properties facili-
tated a high-degree of press-ﬁt while conforming to the contour of
the defect. The results achieved with the sponge were statistically
similar to those of the autograft controls in all histological scoring
categories with the exception of integration, where the sponge was
signiﬁcantly better than the controls. Overall, this study demon-
strates the use of a novel sponge to successfully ﬁll osteochondral
Figure 1. MicroCT images, Saf-O stained sections, Col II stained sections,
and Quantitative T1rho images for sponge-treated defects (A–D) and autograft-
treated defects (E–H).
defects, resulting in repair of the defects with tissue similar in
quality to that of autograft-ﬁlled defects and improved integration
with the surrounding cartilage. Further experimentation is needed
to conﬁrm outcome at later timepoints and in larger defects. The
safety and efﬁcacy of the allograft sponge has not been validated
in human joints.
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Purpose: Cartilage repair still remains a challenge to the main
investigators in the ﬁeld. Cellular therapy is long far away from the
desired regeneration of cartilage for cartilage damage. Our goal is
to get MSC from umbilical cord stroma cells and differentiate them
to obtain chondrocyte-like cells which could be able transplanted
in injured joint to regenerate the tissue. Recent studies from
our lab demonstrate that a new model of chondrogenesis in
vitro is possible using conditioned medium through the spheroid
formation.
Methods: The umbilical cord tissues were obtained from cae-
sareans from normal women in the Maternity Facility at Complejo
Hospitalario Universitario A Coruña under the supervision of the
hospital ethic committee. MSC were isolated and growth from
umbilical cord stroma tissue using an enzymatic digestion and
cultured adhered to the plastic plate. After two passages the
cells were characterized by ﬂow cytometry and immunoﬂuores-
cent analysis. Adypogenesis, osteogenesis and chondrogenesis
was induced to test the mesodermic potential of this population.
Chondrogenic process was performed using our model which
consisted in growing the cells during two days in medium with
FCS 15%. After 2 days the medium was replaced by a medium
with KO serum and TGF-β3. Spheroids were formed by two days
in culture and this three-dimensional structure help to produce the
characteristic protein which form part of the extra-cellular matrix of
cartilage. The spheroids were frozen in OCT at 4, 7, 14, 28 and 46
days in deﬁned medium culture for a posterior protein and genetic
expression by immunohistochemistry and RT-PCR analysis.
Results: The cells were positive for undifferentiated markers like
OCT4, STRO1 and Nanog and for MSC markers like CD90 (90%),
CD44 (25%), CD69 (12%) and CD106 (12%), whereas they were
negative for haematopoietic markers like CD34 and CD45 (less
than 4% and 5% respectively). Using a commercial medium to
induce adipogenesis and osteogenesis, we obtained 100% differ-
